Cargando…

Increasing sensitivity to DNA damage is a potential driver for human ovarian cancer

Ovarian cancer is one of the most common cancers among women, accounting for more deaths than any other gynecological diseases. However, the survival rate for ovarian cancer has not essentially improved over the past thirty years. Thus, to understand the molecular mechanism of ovarian tumorigenesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Yimei, Xu, Xin, Wang, Xuemeng, Kuang, Henry, Osterman, Michael, Feng, Shi, Han, Deqiang, Wu, Yu, Li, Mo, Guo, Hongyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226541/ https://www.ncbi.nlm.nih.gov/pubmed/27391345 http://dx.doi.org/10.18632/oncotarget.10436

Ejemplares similares

Proguanil synergistically sensitizes ovarian cancer cells to olaparib by increasing DNA damage and inducing apoptosis
por: Wu, Yan, et al.
Publicado: (2022)

Tissue specificity of DNA damage response and tumorigenesis
por: Sun, Siman, et al.
Publicado: (2019)

BRCA2 deficiency is a potential driver for human primary ovarian insufficiency
por: Miao, Yilong, et al.
Publicado: (2019)

Helicobacter pylori-Induced DNA Damage Is a Potential Driver for Human Gastric Cancer AGS Cells
por: Shi, Yanyan, et al.
Publicado: (2019)

Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers
por: Birkbak, N J, et al.
Publicado: (2018)

Inhibition of XIAP increases carboplatin sensitivity in ovarian cancer
por: Zhang, Yiping, et al.
Publicado: (2018)

CTCF participates in DNA damage response via poly(ADP-ribosyl)ation
por: Han, Deqiang, et al.
Publicado: (2017)

Does Ovarian Endometriosis Increase Oocyte Sensitivity to ICSI-Induced Mechanical Damage?
por: Scarafia, Carlotta, et al.
Publicado: (2021)

Curcumin-Mediated HDAC Inhibition Suppresses the DNA Damage Response and Contributes to Increased DNA Damage Sensitivity
por: Wang, Shu-Huei, et al.
Publicado: (2015)

Inhibition of PKM2 Enhances Sensitivity of Olaparib to Ovarian Cancer Cells and Induces DNA Damage
por: Zhou, Sichun, et al.
Publicado: (2022)

DNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells
por: Unger, Florian T, et al.
Publicado: (2009)

ENDOGENOUS DNA DAMAGE AS A DRIVER OF AGING AND TISSUE DYSFUNCTION
por: Yousefzadeh, Matt
Publicado: (2022)

Folic acid deficiency increases sensitivity to DNA damage by glucose and methylglyoxal
por: Donnellan, Leigh, et al.
Publicado: (2022)

Berberine induces oxidative DNA damage and impairs homologous recombination repair in ovarian cancer cells to confer increased sensitivity to PARP inhibition
por: Hou, Dong, et al.
Publicado: (2017)

Dysregulation of follicle fatty acid is a potential driver of human primary ovarian insufficiency
por: Wang, Lina, et al.
Publicado: (2020)

DNA damaging agents in ovarian cancer
por: Barretina-Ginesta, Maria-Pilar
Publicado: (2020)

Editorial: Cancer-Associated Defects in the DNA Damage Response: Drivers for Malignant Transformation and Potential Therapeutic Targets
por: van Vugt, Marcel A. T. M., et al.
Publicado: (2015)

Increased Sensitivity of DNA Damage Response-Deficient Cells to Stimulated Microgravity-Induced DNA Lesions
por: Li, Nan, et al.
Publicado: (2015)

Dihydrocoumarin, an HDAC Inhibitor, Increases DNA Damage Sensitivity by Inhibiting Rad52
por: Chen, Chin-Chuan, et al.
Publicado: (2017)

A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents
por: Wilkes, David C., et al.
Publicado: (2017)

Hydroxygenkwanin Increases the Sensitivity of Liver Cancer Cells to Chemotherapy by Inhibiting DNA Damage Response in Mouse Xenograft Models
por: Chen, Chin-Chuan, et al.
Publicado: (2021)

Integrated analysis of DNA methylome and transcriptome reveals SFRP1 and LIPG as potential drivers of ovarian cancer metastasis
por: Yi, Jiani, et al.
Publicado: (2023)

Chloroxine overrides DNA damage tolerance to restore platinum sensitivity in high-grade serous ovarian cancer
por: Silva, Vera L., et al.
Publicado: (2021)

Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells
por: Vella, Serena, et al.
Publicado: (2016)

Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases
por: Shadfar, Sina, et al.
Publicado: (2023)

MEK inhibition leads to BRCA2 downregulation and sensitization to DNA damaging agents in pancreas and ovarian cancer models
por: Vena, Francesca, et al.
Publicado: (2018)

DNA damage repair in ovarian cancer: unlocking the heterogeneity
por: Gee, Mary Ellen, et al.
Publicado: (2018)

Norepinephrine-Induced DNA Damage in Ovarian Cancer Cells
por: Lamboy-Caraballo, Rocio, et al.
Publicado: (2020)

DNA damage repair defects as a new class of endocrine treatment resistance driver
por: Anurag, Meenakshi, et al.
Publicado: (2018)

ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer
por: Feng, Wenlong, et al.
Publicado: (2020)

Increased Sensitivity of PBMCs Isolated from Patients with Rheumatoid Arthritis to DNA Damaging Agents Is Connected with Inefficient DNA Repair
por: Galita, Grzegorz, et al.
Publicado: (2020)

Regulation of the DNA damage response on male meiotic sex chromosomes
por: Lu, Lin-Yu, et al.
Publicado: (2013)

DNA Damage Repair: Predictor of Platinum Efficacy in Ovarian Cancer?
por: Stefanou, Dimitra T., et al.
Publicado: (2021)

Loss of the N-terminal methyltransferase NRMT1 increases sensitivity to DNA damage and promotes mammary oncogenesis
por: Bonsignore, Lindsay A., et al.
Publicado: (2015)

DNA Damage as a Driver for Growth Delay: Chromosome Instability Syndromes with Intrauterine Growth Retardation
por: García-de Teresa, Benilde, et al.
Publicado: (2017)

Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents
por: Kashyap, Trinayan, et al.
Publicado: (2018)

Let-7d increases ovarian cancer cell sensitivity to a genistein analog by targeting c-Myc
por: Ning, Ying-Xia, et al.
Publicado: (2017)

Metabolic modulation of CtBP dimeric status impacts the repression of DNA damage repair genes and the platinum sensitivity of ovarian cancer
por: Li, Jingjing, et al.
Publicado: (2023)

Induced Pluripotent Stem Cells Are Sensitive to DNA Damage
por: Zhang, Minjie, et al.
Publicado: (2013)

Epigenetic mechanisms behind cellular sensitivity to DNA damage
por: Williamson, Amanda K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jonhf3b21dv54fkff4a9t1v31m